These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25816542)

  • 41. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months.
    Ambalavanan N; Tyson JE; Kennedy KA; Hansen NI; Vohr BR; Wright LL; Carlo WA;
    Pediatrics; 2005 Mar; 115(3):e249-54. PubMed ID: 15713907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of vitamin A supplementation in prevention of bronchopulmonary dysplasia in extremely low birth weight neonates: a systematic review of randomized trials.
    Garg BD; Bansal A; Kabra NS
    J Matern Fetal Neonatal Med; 2019 Aug; 32(15):2608-2615. PubMed ID: 29447482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of metabolic bone disease in preterm infants of birth weight <1250 g and in those suffering from bronchopulmonary dysplasia.
    Gaio P; Verlato G; Daverio M; Cavicchiolo ME; Nardo D; Pasinato A; de Terlizzi F; Baraldi E
    Clin Nutr ESPEN; 2018 Feb; 23():234-239. PubMed ID: 29460805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of own mother's milk on bronchopulmonary dysplasia and costs.
    Patel AL; Johnson TJ; Robin B; Bigger HR; Buchanan A; Christian E; Nandhan V; Shroff A; Schoeny M; Engstrom JL; Meier PP
    Arch Dis Child Fetal Neonatal Ed; 2017 May; 102(3):F256-F261. PubMed ID: 27806990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia.
    Shenai JP; Mellen BG; Chytil F
    Pediatrics; 2000 Sep; 106(3):547-53. PubMed ID: 10969101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin A in prevention of bronchopulmonary dysplasia.
    Guimarães H; Guedes MB; Rocha G; Tomé T; Albino-Teixeira A
    Curr Pharm Des; 2012; 18(21):3101-13. PubMed ID: 22564302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
    Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight.
    Watts JL; Milner R; Zipursky A; Paes B; Ling E; Gill G; Fletcher B; Rand C
    Eur Respir J; 1991 Feb; 4(2):188-90. PubMed ID: 2044736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of the level of urinary cysteinyl leukotriene E4 in diagnosis of bronchopulmonary dysplasia in premature infants].
    Jin R; Lu HY; Luo YY; Xu YX; Hu YH; Chen XQ
    Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):703-7. PubMed ID: 27596087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long-term respiratory disability in very-low-birth-weight infants.
    Spears K; Cheney C; Zerzan J
    Am J Clin Nutr; 2004 Dec; 80(6):1589-94. PubMed ID: 15585773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants.
    Collins CT; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS; Travadi J; Berry MJ; Liley HG; Opie GF; Tan K; Lui K; Morris SA; Stack J; Stark MJ; Chua MC; Jayagobi PA; Holberton J; Bolisetty S; Callander IR; Harris DL; Gibson RA
    N Engl J Med; 2017 Mar; 376(13):1245-1255. PubMed ID: 28355511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.
    Marc I; Piedboeuf B; Lacaze-Masmonteil T; Fraser W; Mâsse B; Mohamed I; Qureshi M; Afifi J; Lemyre B; Caouette G; Bartholomew J; Nuyt AM; Julien P; Synnes A; Lucas M; Perreault T; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Massé E; Larsen B; de Cabo C; Ruth C; Khurshid F; Lavoie PM
    JAMA; 2020 Jul; 324(2):157-167. PubMed ID: 32662862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial.
    Ahola T; Lapatto R; Raivio KO; Selander B; Stigson L; Jonsson B; Jonsbo F; Esberg G; Stövring S; Kjartansson S; Stiris T; Lossius K; Virkola K; Fellman V
    J Pediatr; 2003 Dec; 143(6):713-9. PubMed ID: 14657813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of the intramuscular relative-dose-response test to predict bronchopulmonary dysplasia in premature infants.
    Zachman RD; Samuels DP; Brand JM; Winston JF; Pi JT
    Am J Clin Nutr; 1996 Jan; 63(1):123-9. PubMed ID: 8604659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
    Bassler D; Plavka R; Shinwell ES; Hallman M; Jarreau PH; Carnielli V; Van den Anker JN; Meisner C; Engel C; Schwab M; Halliday HL; Poets CF;
    N Engl J Med; 2015 Oct; 373(16):1497-506. PubMed ID: 26465983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants].
    Pan J; Chen MW; Ni WQ; Fang T; Zhang H; Chen Y; Pan JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Feb; 19(2):137-141. PubMed ID: 28202108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
    Finer NN; Carlo WA; Duara S; Fanaroff AA; Donovan EF; Wright LL; Kandefer S; Poole WK;
    Pediatrics; 2004 Sep; 114(3):651-7. PubMed ID: 15342835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nasal CPAP or intubation at birth for very preterm infants.
    Morley CJ; Davis PG; Doyle LW; Brion LP; Hascoet JM; Carlin JB;
    N Engl J Med; 2008 Feb; 358(7):700-8. PubMed ID: 18272893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Colonisation of the airways with ureaplasma urealyticum as a risk factor for bronchopulmonary dysplasia in VLBW infants?].
    Ruf B; Klauwer D; Reiss I; Schiefer HG; Gortner L
    Z Geburtshilfe Neonatol; 2002; 206(5):187-92. PubMed ID: 12395292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nebulized pentoxifylline for reducing the duration of oxygen supplementation in extremely preterm neonates.
    Schulzke SM; Deshmukh M; Nathan EA; Doherty DA; Patole SK
    J Pediatr; 2015 May; 166(5):1158-1162.e2. PubMed ID: 25748566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.